- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05916859
Effectiveness of Photodynamic Therapy in the Disinfection of Root Canals in Patients With Apical Lesion (PDT)
Effectiveness of Photodynamic Therapy Combined With Conventional Endodontic Treatment in the Disinfection of Root Canals in Patients With Apical Lesion: a Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The object of the present study is to compare the effectiveness of conventional endodontic treatment with that of endodontic treatment combined with PDT in patients with apical lesion. A randomized, clinical, superiority trial will be carried out, controlled, blinded and masked, with 3 parallel arms.
The patient sample will be randomized in 3 treatment groups: the first is the placebo group which will receive conventional endodontic treatment (ET) and a simulated treatment with the equipment in which no radiation will be emitted; the second group will receive conventional ET associated with PDT with diode laser at 660 nm, fluence 10 s/canal; and the third group will receive conventional ET associated with PDAT with laser at 660 nm, 20 s/canal. The photosensitizer used in the PDT will be methylene blue.
Clinical and radiographic examination of all the patients will be used to obtain baseline values (T0) and values 6 months post-treatment (T1). The presence and size of apical lesion will be assessed at T0 and T1, the percentage reduction of the lesion will be calculated and the PAI index will be used as a scoring system to assess the lesion. The success rate will be assessed for each group 6 months after completion of the treatment. Disinfection of the root canals will be assessed by analysis of colony formation (ufc/ml); biological samples will be taken with paper cones inserted into the root canals to the apical region at two moments: Baseline (before treatment, T0); after instrumentation with PDT (experimental groups) and without PDT (placebo group). Adverse events will be analysed; a serious adverse event for this study is any unfavourable odontological event that the investigators believe to bear a causal relation with the experimental intervention.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nilton Alves, PhD
- Phone Number: 56 993966898
- Email: nilton.alves@ufrontera.cl
Study Locations
-
-
-
Santiago, Chile
- Recruiting
- Universidad San Sebastián
-
Contact:
- Hector Monardes
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patients eligible for this study must comply with the following for randomization:
- Adult patients of either sex
- No general biological risk
- At least 1 molar with pulp necrosis and apical lesion
Exclusion Criteria:
- Pregnancy
- Patients requiring complex dental rehabilitation due to major coronal destruction
- Individuals with cognitive disability making conventional treatment impossible
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Group 1. Placebo
routine endodontic treatment will be applied and the application of laser will be simulated with the equipment, but no radiation will be emitted
|
Conventional endodontic treatment
|
|
Experimental: Group 2. PDT 10 s
Conventional ET + PDT.
PDT will be carried out with diode laser with optical fibre coupled to the equipment (660 nm, 100 mW, 10 s).
The photosensitizer used will be methylene blue.
|
- Conventional endodontic treatment associated with PDT (10 s)
|
|
Experimental: Group 3: PDT 20 s
Conventional ET + PDAT.
PDAT will be carried out with diode laser with optical fibre coupled to the equipment (660 nm, 100 mW, 20 s).
The photosensitizer used will be methylene blue.
|
Conventional endodontic treatment associated with PDAT (20 s)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in lesion size.
Time Frame: From treatment at 6 months
|
The lesion will be measured vertically and horizontally, and the size difference between the start of treatment and 6 months after treatment will be evaluated.
The lesion will also be evaluated by the PAI index score.
Interpretation of radiographs and PAI scores will be carried out by experienced endodontists.
|
From treatment at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disinfection of the root canals
Time Frame: before treatment (T0) and after treatment (T1)
|
Disinfection of the root canals will be evaluated by analysis of colony formation (ufc/ml).
To assess colony formation (ufc/ml) in the root canal, biological samples will be taken with paper cones inserted into the root canals to the apical region at two moments: Baseline (before treatment, T0); after instrumentation with PDT (experimental groups) and without PDT (placebo group).
Three paper cones will be inserted into the root canals for 30 s. Routine microbiological analysis will be performed.
Disinfection of the canal will be evaluated by comparing colony formation in each group at T0 and T1.
Which treatment promotes the greatest disinfection will also be determined.
|
before treatment (T0) and after treatment (T1)
|
|
Success rate
Time Frame: From treatment at 6 months
|
Success rate of the treatment, measured after 6 months, based on the clinical results (absence of clinical signs and symptoms) and on the radiographic results (diminution of the lesion and absence of root resorption, PAI index score).
The analyses will be carried out by two calibrated researchers, who will be blinded to the patient's assignment to a treatment group.
The success rate will be assessed for each group 6 months after completion of ET.
|
From treatment at 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
adverse events
Time Frame: From treatment at 6 months
|
Primary inferential analysis will be based on intention to treat.
A protocol will be used to analyse the result variable 'adverse effects' to avoid underestimation of its magnitude.
All adverse events will be recorded that occur from entry into the study until completion of treatment.
A serious adverse event for this study is any unfavourable odontological event that the investigators believe to bear a causal relation with the experimental intervention.
|
From treatment at 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nilton Alves, PhD, Universidad de La Frontera
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Folio N°062/21
- DI21-0033 (Other Grant/Funding Number: Diufro)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Periapical Diseases
-
Celalettin TopbaşCompletedPeriapical Periodontitis, Chronic NonsuppurativeTurkey (Türkiye)
-
Faiz ur rahmanNot yet recruitingPeriapical Periodontitis | Periapical Lesion
-
University of Health Sciences LahoreNot yet recruiting
-
Mustafa Kemal UniversityRecruitingApical Periodontitis | Periapical Lesion HealingTurkey (Türkiye)
-
University of SienaRecruitingPulpitis | Periapical Periodontitis | Periapical Lesions | Periapical PathologySpain
-
University of BernRecruiting
-
State University of New York at BuffaloNot yet recruitingPeriapical Periodontitis
-
Aqsa AfzalActive, not recruiting
-
Seyda Ersahan, DDS, PhDCompletedApical Periodontitis | Periapical LesionTurkey (Türkiye)
-
Medipol UniversityCompletedApical Periodontitis | Periapical LesionTurkey
Clinical Trials on Group 1. Placebo
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
University of the Incarnate WordNational Eye Institute (NEI)CompletedColor Vision Defects | Color Blindness | Color Blindness, Red | Color Blindness, GreenUnited States
-
Mersin UniversityNot yet recruiting
-
Tasly Pharmaceutical Group Co., LtdNot yet recruiting
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...PfizerCompletedCeliac Disease | Coeliac DiseaseUnited States, Canada, Finland, Ireland, Israel, Poland, Germany, Netherlands
-
Theravance BiopharmaCompleted
-
UnitedHealth GroupUniversity of Pennsylvania; ProHealth Care AssociatesTerminatedCorona Virus Infection | CoronavirusUnited States
-
MediciNovaTerminatedAsthma | Status AsthmaticusUnited States
-
Bukwang PharmaceuticalTerminatedParkinson Disease | DyskinesiasUnited States
-
Vichy LaboratoiresNot yet recruiting